Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate


Yildirim B. A. , Onal C., Kose F., Oymak E., Sedef A. M. , Besen A. A. , ...More

STRAHLENTHERAPIE UND ONKOLOGIE, vol.195, no.10, pp.872-881, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 195 Issue: 10
  • Publication Date: 2019
  • Doi Number: 10.1007/s00066-019-01429-6
  • Journal Name: STRAHLENTHERAPIE UND ONKOLOGIE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.872-881
  • Hacettepe University Affiliated: Yes

Abstract

Purpose To evaluate the potential benefit of curative radiotherapy (RT) to the primary tumor in metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone.